Journals / BEYOGLU EYE JOURNAL / 2018 / Cilt: 3 - Sayı: 3

Retinopathy of Prematurity Screening Criteria in Turkey’s South Marmara Region

Pages
133–137
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Overall, the screening protocols of ≤33 weeks of GA and ≤2100 g of BW had 100% sensitivity to detect treatment-requiring babies.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objectives: Retinopathy of prematurity (ROP) is the leading cause of preventable blindness in premature infants and a growing problem in the middle- and low-income countries.
📊
Key Findings & Data:Methods: The medical records of the patients who had ROP screening between January 2015 and May 2018 were retro-spectively reviewed.
💡
Conclusion & Impact:Overall, the screening protocols of ≤33 weeks of GA and ≤2100 g of BW had 100% sensitivity to detect treatment-requiring babies.
🔬Design:Review & Systematic Survey
📍Scope:2015 Verileri
⚙️Variables:Domain Parameters

Özet

Objectives: Retinopathy of prematurity (ROP) is the leading cause of preventable blindness in premature infants and a growing problem in the middle- and low-income countries. To prevent ROP, effective screening, prevention, and treatment programs are essential; they should be modified according to each country’s requirements. In this study, we offered mod-ified screening criteria for Turkish children. Methods: The medical records of the patients who had ROP screening between January 2015 and May 2018 were retro-spectively reviewed. Five different criteria were applied to all 1720 babies, as follows: ≤35 weeks and/or 2600 g, ≤34 weeks and/or 2400 g, ≤33 weeks and/or 2100 g, ≤32 weeks and/or 2000 g, and ≤31 weeks and/or 1800 g. The sensitivities and specificities were found for all the strategies. Results: In this study, a total of 1720 babies screened for ROP (774 girls and 946 boys) were evaluated retrospectively. The mean gestational age (GA) of the babies examined was 32.1±2.9 weeks (range 24–36 weeks), and the mean birth weight (BW) of the babies screened was 1817±594 g (range 510–3360 g). ROP was diagnosed in 430 (25%) of the patients, and of these, 165 (9% of all patients) required treatment. Overall, the screening protocols of ≤33 weeks of GA and ≤2100 g of BW had 100% sensitivity to detect treatment-requiring babies. Conclusion: The screening protocols used in highly developed countries are not suitable for all countries, especially for low- and middle-income countries. Thus, the criteria may miss a high number of ROP treatment-requiring patients. Neonatal intensive care unit should coordinate system and continuously updates the ROP screening guidelines so that these data could form a basis for the national ROP standards. We recommend screening premature patients of ≤33 weeks of GA or ≤2100 g of BW for our region.

🔖

Cite This Article

ÇEVİK, S. G., PERENTE, İ. (2018). Retinopathy of Prematurity Screening Criteria in Turkey’s South Marmara Region. BEYOGLU EYE JOURNAL, Cilt: 3 - Sayı: 3, 133–137. https://ajindex.com/articles/148139

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (9)

  1. Blencowe H, Lawn JE, Vazquez T, Fielder A, Gilbert C. Preter-m-associated visual impairment and estimates of retinopathy of prematurity at regional and global levels for 2010. Pediatr Res 2013;74:35–49.
  2. Zin A, Gole GA. Retinopathy of prematurity-incidence today. Clin Perinatol 2013;40:185–200.
  3. Wilson CM, Ells AL, Fielder AR. The challenge of screening for retinopathy of prematurity. Clin Perinatol 2013;40:241–59. Fierson WM; American Academy of Pediatrics Section on Ophthalmology; American Academy of Ophthalmology; Amer-ican Association for Pediatric Ophthalmology and Strabismus; American Association of Certified Orthoptists. Screening ex-amination of premature infants for retinopathy of prematurity. Pediatrics 2013;131:189–95.
  4. Chiang MC, Tang JR, Yau KI, Yang CM. A proposal of screening guideline for retinopathy of prematurity in Taiwan. Acta Paedi-atr Taiwan 2002;43:204–7. International Committee for the Classification of Retinopathy of Prematurity. The International Classification of Retinopathy of Prematurity revisited. Arch Ophthalmol 2005;123:991–9. Good WV; Early Treatment for Retinopathy of Prematurity Cooperative Group. Final results of the Early Treatment for Retinopathy of Prematurity (ETROP) randomized trial. Trans Am Ophthalmol Soc 2004;102:233–50.
  5. Hadi AM, Hamdy IS. Correlation between risk factors during the neonatal period and appearance of retinopathy of pre-maturity in preterm infants in neonatal intensive care units in Alexandria, Egypt. Clin Ophthalmol 2013;7:831–7.
  6. Roohipoor R, Karkhaneh R, Farahani A, Ebrahimiadib N, Modj-tahedi B, Fotouhi A, et al. Retinopathy of prematurity screening criteria in Iran: new screening guidelines. Arch Dis Child Fetal Neonatal Ed 2016;101:F288–93. Charan R, Dogra MR, Gupta A, Narang A. The incidence of retinopathy of prematurity in a neonatal care unit. Indian J Oph-thalmol 1995;43:123–6.
  7. Holmström G, Hellström A, Jakobsson P, Lundgren P, Tornqvist K, Wallin A. Evaluation of new guidelines for ROP screening in Sweden using SWEDROP - a national quality register. Acta Ophthalmol 2015;93:265–8.
  8. Chiang MF, Arons RR, Flynn JT, Starren JB. Incidence of retinopathy of prematurity from 1996 to 2000: analysis of a comprehensive New York state patient database. Ophthalmol-ogy 2004;111:1317–25.
  9. Lee SK, Normand C, McMillan D, Ohlsson A, Vincer M, Lyons C; Canadian Neonatal Network. Evidence for changing guide-lines for routine screening for retinopathy of prematurity. Arch Pediatr Adolesc Med 2001;155:387–95. Binen